In the midst of the COVID-19 pandemic, an unexpected intersection has emerged between the virus and atopic dermatitis (AD). As healthcare professionals grapple with the challenges posed by COVID-19, new insights are being uncovered regarding its effects on individuals with pre-existing skin conditions. Atopic dermatitis, characterized by chronic inflammation and skin barrier dysfunction, has seen exacerbations during this global health crisis. The interplay between psychological stress, immune dysregulation, and disruptions in routine care has significantly influenced the course of AD for many patients. Furthermore, the introduction of COVID-19 vaccinations raises critical questions about their safety and efficacy in this population, particularly regarding reported dermatological reactions and the immune response. Understanding these dynamics is essential for optimizing management strategies and improving patient outcomes during the pandemic. This chapter aims to elucidate the complex relationship between COVID-19, its vaccinations, and atopic dermatitis exacerbations, providing a comprehensive overview of the current state of research and future directions for study.